Regulation of ryanodine receptor-mediated calcium signaling by presenilins

Andrew J. Payne, Simon Kaja, Peter Koulen

Abstract


Ca2+ dyshomeostasis is a critical causative mechanism underlying the functional impairment of the central nervous system seen in ‘healthy’ aging [1], specifically in normal brain aging processes in the absence of disease-causing mutations or external causes. It is generally thought that such impairments result from the gradual accumulation of small changes at the molecular level, such as oxidative damage to the structure and function of synapses, that ultimately cause the loss of biological function [2].  Alzheimer’s disease (AD) is a multifactorial pathology directly related to aging and with age as a primary risk factor [3].  Neurons affected by AD have an elevated cytosolic calcium ion concentration [4].  It has not yet been determined if the observed elevation of cytosolic calcium is contributing to or results from AD pathology, but there is mounting evidence in support of the Calcium Hypothesis of brain aging [4-9].  The two presenilin genes found in vertebrates are ubiquitously expressed as the transmembrane proteins presenilin-1 (PS1) and presenilin-2 (PS2), respectively, in the endoplasmic reticulum (ER). They  are part of the γ-secretase enzyme complex catalyzing the processing of amyloid precursor protein (APP), which - if aberrant under disease conditions - can result in the generation of neurotoxic amyloid-beta (Aβ) peptides [10] (Fig. 1).  Approximately 80% of the mutations linked to familial AD have been found in PS1 [11] and clinically relevant PS1 mutations exert effects on cytosolic calcium concentrations [10, 12].  While both presenilins affect cytosolic calcium concentrations, the PS1 isoform binds to several proteins essential to the regulation of intracellular calcium signaling, e.g. the inositol 1,4,5-trisphosphate receptor (IP3R) [13], the N-methyl-D-aspartate (NMDA) receptor (NMDAR) [14], and the ryanodine receptor (RyR) [15-17].  Here, the interaction of presenilins with RyRs will be reviewed.

 

PMID: 25646163 [PubMed]


Full Text:

PDF

References


Sama DM, Norris CM. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction. Ageing Res Rev 2013;12:982-995.

Hayflick L. Biological Aging Is No Longer an Unsolved Problem. Ann N Y Acad Sci 2007;1100:1-13.

Alzheimer's Association. 2012 Alzheimer's disease facts and figures. Alzheimers Dement 2012;8:131-168.

Khachaturian ZS. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 1987;8:345-346.

Khachaturian ZS. Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview. Ann N Y Acad Sci 1989;568:1-4.

Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007;6:307-317.

Landfield PW, Pitler TA. Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science. 1984;226:1089-1092.

Landfield PW. 'Increased calcium-current' hypothesis of brain aging. Neurobiol Aging 1987;8:346-347.

Landfield PW. Hippocampal neurobiological mechanisms of age-related memory dysfunction. Neurobiol Aging 1988;9:571-579.

LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002;3:862-872.

Elder GA, Gama Sosa MA, De Gasperi R, Dickstein DL, Hof PR. Presenilin transgenic mice as models of Alzheimer's disease. Brain Struct Funct 2010;214:127-143.

Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A. Presenilin-mediated signal transduction. Physiol Behav 2007;92:93-97.

Cheung KH, Shineman D, Muller M, Cardenas C, Mei L, Yang J, et al. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008;58:871-883.

Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, et al. Presenilins are essential for regulating neurotransmitter release. Nature. 2009;460:632-636.

Rybalchenko V, Hwang SY, Rybalchenko N, Koulen P. The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. Int J Biochem Cell Biol 2008;40:84-97.

Hayrapetyan V, Rybalchenko V, Rybalchenko N, Koulen P. The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction. Cell Calcium 2008;44:507-518.

Payne AJ, Gerdes BC, Naumchuk Y, McCalley AE, Kaja S, Koulen P. Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines. Exp Neurol 2013;250:143-150.

Thakur MK, Ghosh S. Age and sex dependent alteration in presenilin expression in mouse cerebral cortex. Cell Mol Neurobiol 2007;27:1059-1067.

Kaja S, Sumien N, Shah VV, Puthawala I, Maynard AN, Khullar N, et al. Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels. Mol Neurobiol 2014; Sep 10. [Epub ahead of print]

Collier TJ, Coleman PD. Divergence of biological and chronological aging: evidence from rodent studies. Neurobiol Aging 1991;12:685-693.

Nguyen PV. Comparative plasticity of brain synapses in inbred mouse strains. J Exp Biol 2006;209:2293-2303.




DOI: http://dx.doi.org/10.14800/rci.449

Refbacks

  • There are currently no refbacks.




Copyright (c) 2014 Andrew J. Payne, Simon Kaja, Peter Koulen

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.